These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Major G, Spiller R. Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):15-21. PubMed ID: 24296462 [Abstract] [Full Text] [Related]
4. Gut microbiota and probiotics in colon tumorigenesis. Zhu Y, Michelle Luo T, Jobin C, Young HA. Cancer Lett; 2011 Oct 28; 309(2):119-27. PubMed ID: 21741763 [Abstract] [Full Text] [Related]
5. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. Tomasello G, Tralongo P, Damiani P, Sinagra E, Di Trapani B, Zeenny MN, Hussein IH, Jurjus A, Leone A. World J Gastroenterol; 2014 Dec 28; 20(48):18121-30. PubMed ID: 25561781 [Abstract] [Full Text] [Related]
7. The human gut microbiome: implications for future health care. Kinross JM, von Roon AC, Holmes E, Darzi A, Nicholson JK. Curr Gastroenterol Rep; 2008 Aug 28; 10(4):396-403. PubMed ID: 18627653 [Abstract] [Full Text] [Related]
8. Gut microbiota and the role of probiotics in therapy. Quigley EM. Curr Opin Pharmacol; 2011 Dec 28; 11(6):593-603. PubMed ID: 21996283 [Abstract] [Full Text] [Related]
9. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer. Jackson DN, Theiss AL. Gut Microbes; 2020 May 03; 11(3):285-304. PubMed ID: 30913966 [Abstract] [Full Text] [Related]
10. Microbiota regulation of inflammatory bowel disease and colorectal cancer. Liu Z, Cao AT, Cong Y. Semin Cancer Biol; 2013 Dec 03; 23(6 Pt B):543-52. PubMed ID: 24071482 [Abstract] [Full Text] [Related]
11. Altered intestinal microbiota in irritable bowel syndrome. Lee KJ, Tack J. Neurogastroenterol Motil; 2010 May 03; 22(5):493-8. PubMed ID: 20414959 [Abstract] [Full Text] [Related]
12. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, Dekens J, Peters V, Voskuil MD, Visschedijk MC, van Dullemen HM, Keszthelyi D, Swertz MA, Franke L, Alberts R, Festen EAM, Dijkstra G, Masclee AAM, Hofker MH, Xavier RJ, Alm EJ, Fu J, Wijmenga C, Jonkers DMAE, Zhernakova A, Weersma RK. Sci Transl Med; 2018 Dec 19; 10(472):. PubMed ID: 30567928 [Abstract] [Full Text] [Related]
13. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi JR. Dig Dis Sci; 2010 Feb 19; 55(2):392-7. PubMed ID: 19693670 [Abstract] [Full Text] [Related]
14. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Whelan K, Quigley EM. Curr Opin Gastroenterol; 2013 Mar 19; 29(2):184-9. PubMed ID: 23286925 [Abstract] [Full Text] [Related]